CONFLICT OF INTEREST
Haeberlin A. is Co-founder and CEO of Act-Inno AG, consultant of Cairdac and has received travel/educational grants from Medtronic and Spectranetics/Philips.
The spouse of Seiler J. is an employee of Boston Scientific.
Noti F. has received travel grant from Abbott, Medtronic, Boston Scientific and Spectranetics.
Tanner H. has received travel grant from Abbott and educational grant from Biosense Webster.
Windecker St. reports research and educational grants to the institution from Abbott, Amgen, BMS, Bayer, Boston Scientific, Biotronik, Cardinal Health, CardioValve, CSL Behring, Daiichi Sankyo, Edwards Lifesciences, Johnson&Johnson, Medtronic, Querbet, Polares, Sanofi, Terumo, Sinomed.
Windecker St. serves as unpaid advisory board member and/or unpaid member of the steering/executive group of trials funded by Abbott, Abiomed, Amgen, Astra Zeneca, BMS, Boston Scientific, Biotronik, Cardiovalve, Edwards Lifesciences, MedAlliance, Medtronic, Novartis, Polares, Sinomed, V-Wave and Xeltis, but has not received personal payments by pharmaceutical companies or device manufacturers. He is also member of the steering/excecutive committee group of several investigated-initiated trials that receive funding by industry without impact on his personal remuneration. Windecker St. is an unpaid member of the Pfizer Research Award selection committee in Switzerland.
Reichlin T. has received speaker/consulting honoraria or travel support from Abbott/SJM, Astra Zeneca, Brahms, Bayer, Biosense-Webster, Medtronic, Pfizer-BMS and Roche and he has received support for his institution’s fellowship program from Biosense-Webster, Biotronik, Medtronic, Abbott/SJM and Boston Scientific.
Roten L. has received speaker honoraria from Abbott and Medtronic. The other authors have no potential conflict of interest relevant to this article.